FDA approval: Sermorelin = pediatric GH deficiency only (branded version discontinued 2008)
doi: 10.1016/S0741-8329(02)00229-X 69
It differs from ALCAR, which is often used for cognitive support
Add liquid slowly during reconstitution Aim down the vial wall, not directly onto lyophilized powder

Provail is a convenient, shelf-stable form of glutathione that boasts 2.5x better bioavailability than the leading competitor1.* It works better, faster, and goes deeper to help maintain a healthy immune system, soothe the digestive tract, and help the mind to think clearly.* Davincis NAD+ Activate with Glutathione is a healthy aging formula that supports levels of NAD+, adenosine triphosphate (ATP) the source of energy at the cellular level and glutathione all at once.* This supplement helps adults to stay energized and active and helps maintain normal levels of cortisol, the adrenal stress hormone, to support the body during times of tension.* It supports insulin sensitivity and can help maintain healthy blood sugar levels, and can even help support memory and cognitive function.* More Information Suggested Use: As a dietary supplement, take 2 capsules daily, or as directed by your healthcare practitioner

Side Effects & Safety Typical first-cycle side effects: Weeks 1-2: mild water retention, vivid dreams, light head/warmth after injection Weeks 3-4: occasional joint stiffness, improved sleep quality, slight appetite increase overnight Weeks 5-8: adaptation phase most side effects fade, body composition changes visible Clinical discontinuation signals (trial-reported): Clinical participants in tesamorelin studies were discontinued upon experiencing: Persistent headaches with visual changes (intracranial pressure marker in trial monitoring protocols) Sustained fasting glucose elevation of ~15 mg/dL above baseline Unusual peripheral swelling persisting beyond weeks 1-2 Carpal tunnel symptoms unresponsive to dose titration in community-reported protocols Tesamorelin has been studied at 2mg/day for 6+ months without notable safety signals at therapeutic doses